BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19110314)

  • 1. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities.
    Aureliano M; Crans DC
    J Inorg Biochem; 2009 Apr; 103(4):536-46. PubMed ID: 19110314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration.
    Soares SS; Martins H; Duarte RO; Moura JJ; Coucelo J; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 Jan; 101(1):80-8. PubMed ID: 17030392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decavanadate effects in biological systems.
    Aureliano M; Gândara RM
    J Inorg Biochem; 2005 May; 99(5):979-85. PubMed ID: 15833319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decavanadate induces mitochondrial membrane depolarization and inhibits oxygen consumption.
    Soares SS; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2007 May; 101(5):789-96. PubMed ID: 17349695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadate oligomers: in vivo effects in hepatic vanadium accumulation and stress markers.
    Gândara RM; Soares SS; Martins H; Gutiérrez-Merino C; Aureliano M
    J Inorg Biochem; 2005 May; 99(5):1238-44. PubMed ID: 15833347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria as a target for decavanadate toxicity in Sparus aurata heart.
    Soares SS; Gutiérrez-Merino C; Aureliano M
    Aquat Toxicol; 2007 Jun; 83(1):1-9. PubMed ID: 17420061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vanadium distribution following decavanadate administration.
    Soares SS; Martins H; Aureliano M
    Arch Environ Contam Toxicol; 2006 Jan; 50(1):60-4. PubMed ID: 16151690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate.
    Ramos S; Manuel M; Tiago T; Duarte R; Martins J; Gutiérrez-Merino C; Moura JJ; Aureliano M
    J Inorg Biochem; 2006 Nov; 100(11):1734-43. PubMed ID: 16890293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decavanadate: a journey in a search of a role.
    Aureliano M
    Dalton Trans; 2009 Nov; (42):9093-100. PubMed ID: 20449180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances into vanadyl, vanadate and decavanadate interactions with actin.
    Ramos S; Moura JJ; Aureliano M
    Metallomics; 2012 Jan; 4(1):16-22. PubMed ID: 22012168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decavanadate in vitro and in vivo effects: facts and opinions.
    Aureliano M; Ohlin CA
    J Inorg Biochem; 2014 Aug; 137():123-30. PubMed ID: 24865633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadium and cadmium in vivo effects in teleost cardiac muscle: metal accumulation and oxidative stress markers.
    Soares SS; Martins H; Gutiérrez-Merino C; Aureliano M
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Mar; 147(2):168-78. PubMed ID: 17920336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actin as a potential target for decavanadate.
    Ramos S; Moura JJ; Aureliano M
    J Inorg Biochem; 2010 Dec; 104(12):1234-9. PubMed ID: 20807665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ion pumps as biological targets for decavanadate.
    Aureliano M; Fraqueza G; Ohlin CA
    Dalton Trans; 2013 Sep; 42(33):11770-7. PubMed ID: 23636581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition.
    Fraqueza G; Batista de Carvalho LA; Marques MP; Maia L; Ohlin CA; Casey WH; Aureliano M
    Dalton Trans; 2012 Nov; 41(41):12749-58. PubMed ID: 22968713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decavanadate interactions with actin: cysteine oxidation and vanadyl formation.
    Ramos S; Duarte RO; Moura JJ; Aureliano M
    Dalton Trans; 2009 Oct; (38):7985-94. PubMed ID: 19771361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanadate induces necrotic death in neonatal rat cardiomyocytes through mitochondrial membrane depolarization.
    Soares SS; Henao F; Aureliano M; Gutiérrez-Merino C
    Chem Res Toxicol; 2008 Mar; 21(3):607-18. PubMed ID: 18251508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of mineralization by metavanadate and decavanadate solutions in a fish bone-derived cell line.
    Tiago DM; Laizé V; Cancela ML; Aureliano M
    Cell Biol Toxicol; 2008 Jun; 24(3):253-63. PubMed ID: 17899405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EXAFS Approach to the Study of Polyoxometalate-Protein Interactions: The Case of Decavanadate-Actin.
    Marques MPM; Gianolio D; Ramos S; Batista de Carvalho LAE; Aureliano M
    Inorg Chem; 2017 Sep; 56(18):10893-10903. PubMed ID: 28858484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
    Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
    Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.